Pure Global

READY-TO-USE SYRINGE CONTAINING EVENITY 105 MG/1.17 ML SOLUTION FOR INJECTION, 2 PCS - Turkey License 4007bc9b3d3b9b1a181c0c2a6a1ff855

Access comprehensive regulatory information for READY-TO-USE SYRINGE CONTAINING EVENITY 105 MG/1.17 ML SOLUTION FOR INJECTION, 2 PCS in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number 4007bc9b3d3b9b1a181c0c2a6a1ff855 with license number 2022/104and contains active ingredient Romosozumab . The license is held by AMGEN İLAÇ TİC. LTD. ŞTİ..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
21,000+ Products
4007bc9b3d3b9b1a181c0c2a6a1ff855
License Details
Turkey SFDA License: 4007bc9b3d3b9b1a181c0c2a6a1ff855
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Product Details

READY-TO-USE SYRINGE CONTAINING EVENITY 105 MG/1.17 ML SOLUTION FOR INJECTION, 2 PCS
TR: EVENİTY 105 MG/1,17 ML ENJEKSİYONLUK ÇÖZELTİ İÇEREN KULLANIMA HAZIR ENJEKTÖR, 2 ADET
Pharmaceutical Product

License Details

4007bc9b3d3b9b1a181c0c2a6a1ff855

2022/104

8699862950244

M05BX06

License Holder Information

Active Ingredient

Romosozumab

License Information

Mar 08, 2022